MiR-124-3p inhibits the migration and invasion of Gastric cancer by targeting ITGB3

• Published in: Pathology, research and practice research and practice, 2020-01, Vol.216 (1), p.152762-152762, Article 152762
• Main Authors: Wu, Qian, Zhong, Huiyu, Jiao, Lin, Wen, Yang, Zhou, Yi, Zhou, Juan, Lu, Xiaojun, Song, Xingbo, Ying, Binwu
• Format: Article
• Language: English
• Subjects: Gastric cancer; Integrin; Mechanism; MicroRNA; Tumor migration and invasion
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2019.152762

Gastric cancer is one of the major malignant tumors in the world. Integrins expressed in cancer cells can promote tumor progression and migration. MiRNAs can inhibit the expression of target genes by directly binding to their mRNAs and can affect various important biological processes. The aim of this study was to investigate the role of miR-124- 3p and ITGB3 in gastric cancer. RT-PCR and western blot are used to detect the expression of miR-124-3p, ITGB3 and integrin β3 in gastric cancer tissues and cells. The wound healing, CCK-8 assay, transwell migration and invasion assay were performed to determine the cell proliferation, migration and invasion. What’s more, bioinformatics prediction and luciferase assay was conducted to demonstrated the binding efficiency between miR-124-3p and ITGB3. We verified that ITGB3 and miR-124-3p changes the migration and invasion of gastric cancer cells in vitro. The overexpression or silencing of miR-124-3p inhibited or promoted the proliferation, migration and invasion of both selected gastric cancer cells, and ITGB3 is just the reverse. Meanwhile, we validated that ITGB3 is the target of miR-124-3p by bioinformatics prediction and luciferase assay. Lastly, the expression of ITGB3 in 40 pairs of gastric cancer tissues were significantly higher than that in the adjacent normal tissues, while the expression level of miR-124-3p was significantly decreased in cancer tissues. miR-124-3p inhibits the migration and invasion of Gastric cancer by targeting ITGB3 in gastric cancer cells. Our results suggested that miR-124-3p and ITGB3 may reasonably serve as a promising therapeutic target.